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OBJECTIVE—A number of studies have found that reduced
birth weight is associated with type 2 diabetes later in life;
however, the underlying mechanism for this correlation remains
unresolved. Recently, association has been demonstrated be-
tween low birth weight and single nucleotide polymorphisms
(SNPs) at the CDKAL1 and HHEX-IDE loci, regions that were
previously implicated in the pathogenesis of type 2 diabetes. In
order to investigate whether type 2 diabetes risk–conferring
alleles associate with low birth weight in our Caucasian child-
hood cohort, we examined the effects of 20 such loci on this trait.
RESEARCH DESIGN AND METHODS—Using data from an
ongoing genome-wide association study in our cohort of 5,465
Caucasian children with recorded birth weights, we investigated
the association of the previously reported type 2 diabetes–
associated variation at 20 loci including TCF7L2, HHEX-IDE,
PPARG, KCNJ11, SLC30A8, IGF2BP2, CDKAL1, CDKN2A/2B,
and JAZF1 with birth weight.
RESULTS—Our data show that the minor allele of rs7756992
(P  8  10
5)a tt h eCDKAL1 locus is strongly associated with
lower birth weight, whereas a perfect surrogate for variation
previously implicated for the trait at the same locus only yielded
nominally signiﬁcant association (P  0.01; r
2 rs7756992 
0.677). However, association was not detected with any of the
other type 2 diabetes loci studied.
CONCLUSIONS—We observe association between lower
birth weight and type 2 diabetes risk–conferring alleles at the
CDKAL1 locus. Our data show that the same genetic locus that
has been identiﬁed as a marker for type 2 diabetes in previous
studies also inﬂuences birth weight. Diabetes 58:2414–2418,
2009
I
t has been reported that reduced birth weight is
associated with an increased risk of type 2 diabetes
later in life (1–3). The largest such study was a
meta-analysis of 14 studies involving a total of
132,180 individuals that demonstrated an association be-
tween lower birth weight and type 2 diabetes risk with an
odds ratio of 1.32 (2). On a global level, reduced birth
weight has been shown to be correlated with increased
type 2 diabetes risk in 28 of 31 populations studied (3).
Furthermore, low birth weight has been associated with
both type 2 diabetes (P  0.008) and impaired insulin
secretion (P  0.04) in 2,003 participants from the Helsinki
Birth Cohort Study (HBCS) (4).
It has been proposed that the relationship between low
birth weight and type 2 diabetes is genetically mediated,
namely, the fetal insulin hypothesis (5,6). Because insulin
is a key fetal growth factor, the genetic variants that
reduce insulin secretion or insulin sensitivity might also
reduce birth weight as well as increase the risk of devel-
oping type 2 diabetes later in life (5,6).
Studies of monogenic diabetes support the fetal insulin
hypothesis where gene mutations such as GCK, INS,
INSR, and KCNJ11 have been shown to track with both
low birth weight and diabetes (5,7,8). It has also been
shown from epidemiological studies that paternal genetic
contributions can directly predispose the offspring to
general type 2 diabetes through reduced birth weight (9),
whereas the maternal genetic contribution to the trait is
less clear because it is more difﬁcult to separate the
inﬂuence of genes transferred from mother to offspring
from that of the maternal environment (which in turn may
be inﬂuenced by the mother’s own genes) (10,11).
Recent genome-wide association (GWA) studies of type
2 diabetes have revealed a number of loci (12–22), some of
which have been subsequently explored in the context of
birth weight. In the HBCS study, the type 2 diabetes
risk–conferring allele in HHEX-IDE yielded a trend
toward low birth weight, whereas the equivalent allele
at the CDKN2A/2B locus was associated with high birth
weight; in addition, risk variants at HHEX-IDE, CDKN2A/
2B, and JAZF1 genes were shown to interact with birth
weight but not TCF7L2, PPARG, KCNJ11, SLC30A8,
IGF2BP2, and CDKAL1. Indeed, the highest risk of going
on to develop type 2 diabetes was among the lower birth
weight participants carrying the implicated risk variants
(4). More recently, examination in four studies of Cauca-
sian Europeans consisting of 7,986 mothers and 19,200
offspring of the ﬁve type 2 diabetes genes CDKAL1,
CDKN2A/2B, HHEX-IDE, IGF2BP2, and SLC30A8 with
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KAL1 and HHEX-IDE when inherited by the fetus but not
for CDKN2A/2B, IGF2BP2, and SLC30A8 (6).
In this study, we sought to clarify these reported asso-
ciations between low birth weight and type 2 diabetes loci
using data from an ongoing GWA study in a cohort of 5,465
European American children with recorded birth weights.
The criteria for locus selection were that they either came
directly from published type 2 diabetes GWA studies or
were type 2 diabetes genes found through the candidate
gene approach that have also been reported to be associ-
ated with birth weight previously. We queried for known
variants at the type 2 diabetes–associated loci of TCF7L2,
HHEX-IDE, PPARG, KCNJ11, SLC30A8, IGF2BP2,
CDKAL1, CDKN2A/2B, and JAZF1 with respect to their
correlation with birth weight to directly compare and
contrast with what was recently reported by two Euro-
pean groups (4,6). We also queried for an additional 11
established type 2 diabetes loci that have not been previ-
ously reported with respect to birth weight including
MNTR1B, which was ﬁrst implicated in multiple GWA
studies of the related trait of fasting glucose and was
subsequently associated with type 2 diabetes within the
same studies (15,17,22).
RESEARCH DESIGN AND METHODS
Research subjects
European American Pediatric cohort from Philadelphia. All subjects
were consecutively recruited from the greater Philadelphia area from 2006–
2009 at the Children’s Hospital of Philadelphia. Our study cohort consisted of
5,465 singleton children of European ancestry with recorded birth weight
information. We did not observe a cohort effect or temporal trends in the data.
All of these participants had their blood drawn in an 8-ml ethylenediamine
tetraacetic acid blood collection tube and subsequently DNA extracted for
genotyping. All subjects were biologically unrelated and were aged 0–21
years. This study was approved by the Institutional Review Board of The
Children’s Hospital of Philadelphia. Parental informed consent was given for
each study participant for both the blood collection and subsequent
genotyping.
Genotyping
Illumina Inﬁnium assay. We performed high-throughput genome-wide
single nucleotide polymorphism (SNP) genotyping using the Illumina Inﬁnium
II HumanHap550 or Human 610 BeadChip technology (Illumina, San Diego,
CA) at The Children’s Hospital of Philadelphia’s Center for Applied Genomics,
as described previously (23). The SNPs analyzed survived the ﬁltering of the
genome-wide dataset for SNPs with call rates 95%, minor allele frequency
1%, missing rate per person 2%, and Hardy-Weinberg equilibrium P  10
5.
Most loci described from GWA studies published to date have been found
using either the Affymetrix or Illumina platform. In the event a locus was
reported using both the Illumina and Affymetrix arrays, we used the SNPs
present on the Illumina array. In the event of a signal only being described on
the Affymetrix array, we either already had that SNP on our Illumina array or
identiﬁed and used the best surrogate SNP available based on the CEU
HapMap (supplementary Table 1, available in the online appendix at http://
diabetes.diabetesjournals.org/cgi/content/full/db09-0506/DC1). We used two
SNPs at the CDKAL1 (rs4712523 and rs7756992; r
2  0.677), HHEX-IDE
(rs1111875 and rs7923837; r
2  0.698), and PPARG (rs17793693 and rs6802898;
r
2  0.011) loci as the association with type 2 diabetes, taken from various
GWA studies that reported various SNPs that were in imperfect linkage
disequilibrium with each other. In addition, rs4712523 is a proxy (r
2  1) for
rs10946398, which was previously associated with birth weight.
Analysis
Normalization of birth weight data. From our database, we eliminated
outliers with birth weight 1o r8 kg, i.e., those individuals not within the
credible range for birth weight at term, to avoid the potential consequences of
error or Mendelian causes of extreme birth weight. Each birth weight value
was adjusted for each sex separately then expressed as a z score.
Association. We queried the data for the SNPs of interest in our pediatric
sample. All statistical analyses were carried out using the software package
PLINK v. 1.05 (24). Ethnicity for our cohort was derived using the multidi-
mensional scaling feature within PLINK. By treating birth weight as a
quantitative trait (treated as a z score after correcting for sex), association
analysis for each SNP was carried out using linear regression analysis with the
SNP included as an independent variable (coded as 0, 1, and 2). With 5,465
subjects, the powers to detect 0.2, 0.3, 0.4, 0.5, 0.6, 0.8, and 1% variation at the
P  0.002 level (i.e., the corrected P value for the number of tests) were 47.4,
74.6, 90.0, 96.6, 98.9, 100, and 100%, respectively.
RESULTS
In our initial analysis, 12 SNPs corresponding to the 9 type
2 diabetes loci previously studied in the context of birth
weight were investigated in our cohort, namely, TCF7L2,
HHEX-IDE, PPARG, KCNJ11, SLC30A8, IGF2BP2,
CDKAL1, CDKN2A/2B, and JAZF1 (4,6) (Table 1).
As a result, we observed strong association with
rs7756992 (P  8 10
5)a tt h eCDKAL1 locus with low
birth weight; this SNP yielded strongest association to
type 2 diabetes in an Icelandic GWA study carried out
on the Illumina HumanHap500 platform (21). SNPs
rs10946398 or rs7754840 at the same locus have been
reported to be most strongly associated with type 2
diabetes from GWA studies on the Affymetrix platform or
the Illumina HumanHap300 BeadChip (16,18,19); however,
using a perfect surrogate, rs4712523 (r
2  1), we only
observed nominally signiﬁcant association (P  0.01). It
TABLE 1
Quantitative association results for previously studied type 2 diabetes risk alleles with birth weight in the European American cohort
(n  5,465), sorted by chromosomal location
Chromosome SNP
Minor
allele MAF BP
Nearby
gene n  SE r
2 T P
3 rs17793693 A* 0.09634 12320971 PPARG 5,465 0.04854 0.03254 0.0004072 1.492 0.1358
3 rs6802898 T* 0.1212 12366207 PPARG 5,460 0.03545 0.02948 0.0002648 1.202 0.2293
3 rs4402960 T 0.3263 186994389 IGF2BP2 5,461 0.01568 0.02017 0.0001107 0.7774 0.4369
6 rs4712523 G 0.3204 20765543 CDKAL1 5,465 0.05303 0.02068 0.001202 2.564 0.01037
6 rs7756992** G 0.2794 20787688 CDKAL1 5,464 0.08449 0.0214 0.002846 3.948 7.97  10
5
7 rs1635852 T* 0.4941 27962651 JAZF1 5,464 0.007681 0.01921 2.93E-05 0.3998 0.6893
8 rs13266634 T* 0.2969 118253964 SLC30A8 5,460 0.01721 0.02102 0.0001228 0.8189 0.4129
9 rs2383207 G* 0.4583 22105959 CDKN2A/B 5,465 0.003944 0.01933 7.63E-06 0.2041 0.8383
10 rs1111875 T* 0.4027 94452862 HHEX-IDE 5,465 0.004147 0.01949 8.29E-06 0.2128 0.8315
10 rs7923837 A* 0.3822 94471897 HHEX-IDE 5,465 0.005545 0.01967 1.46E-05 0.2819 0.778
10 rs7903146 T 0.3057 114748339 TCF7L2 5,465 0.007205 0.02069 2.22E-05 0.3482 0.7277
11 rs1557765 T 0.3685 17360215 KCNJ11 5,457 0.002475 0.0199 2.84E-06 0.1244 0.901
The direction of effect is shown for the minor allele in each case. *Major allele previously reported to be associated with type 2 diabetes;
**P  0.002. , regression coefﬁcient for the test SNP; BP, base pair position; MAF, minor allele frequency; n, number of subjects tested; P,
two-sided trend test P value; r
2, value in linear regression; T, test statistic.
J. ZHAO AND ASSOCIATES
diabetes.diabetesjournals.org DIABETES, VOL. 58, OCTOBER 2009 2415should be noted that rs10946398 and rs7756992 are far
from being in perfect linkage disequilibrium (r
2  0.677),
thus the inclusion of both in this current study.
Unlike previous reports, we did not observe association
between rs1111875 at the HHEX-IDE locus and this trait
(6). In line with previous reports, we also did not observe
association between birth weight and TCF7L2, PPARG,
KCNJ11, SLC30A8, IGF2BP2, CDKN2A/2B,o rJAZF1
(4,6,10).
Furthermore, we did not observe any signiﬁcant associ-
ation with risk alleles at other type 2 diabetes loci after
correction for multiple testing for all 23 SNPs (threshold
P  0.002) (supplementary Table 2). We detected nominal
association with rs1387153 (P  0.02) at the MTNR1B
locus; however, the corresponding type 2 diabetes risk
allele was tracking with higher birth weight. We also
analyzed male and female subjects separately, but the
effect of each locus on birth weight did not vary by sex
(supplementary Tables 3 and 4).
DISCUSSION
From this interim analysis of our ongoing GWA study of
birth weight in a European American cohort, it is clear that
the CDKAL1 locus, which was uncovered in GWA analy-
ses of type 2 diabetes, is strongly associated with birth
weight in our study population. This result clearly sup-
ports a previous report that came to a similar conclusion
(6). However, the study by Freathy et al. used a different
SNP, namely, rs10946398, which was not present on our
Illumina BeadChip; we used a perfect surrogate, i.e.,
rs4712523 (r
2  1), that only yielded nominal signiﬁcance
(P  0.01). Although they did not report for rs7756992,
we found that it gave us the strongest association (P 
8 10
5) and was selected for this study because it yielded
the strongest association to type 2 diabetes in an Icelandic
GWA study (21).
Secondly, we did not observe association between
HHEX-IDE and birth weight, which is in contrast with
what had been described previously (6). We acknowledge
that our cohort is smaller than the original report (5,465 vs.
19,200 individuals); indeed, this association was not ob-
served (P  0.05) in the similarly sized 1958 birth cohort
(6). The lack of available covariate data, such as gesta-
tional age, was also a limitation of this study. Therefore, it
is possible that with a larger cohort with additional
covariate data we may observe the association of this
locus with birth weight; however, it could also indicate
that HHEX-IDE has a less pronounced impact on birth
weight than CDKAL1.
Consistent with the existing literature, we did not
ﬁnd any evidence of association between birth weight
and TCF7L2, PPARG, KCNJ11, SLC30A8, IGF2BP2,
CDKN2A/2B,o rJAZF1 (4,6,10). Given the monogenic
precedent for opposing effects of maternal and fetal geno-
type (25), it is possible that effects of common type 2
diabetes alleles could be masked by this phenomenon.
The exact function of CDKAL1 is unknown. It has been
shown that CDKAL1 is expressed in the rat pancreatic
-cell line Ins-1 (21). Homozygous carriers of the risk
allele have been shown to have a 22% lower corrected
insulin response than individuals who are wild-type carri-
ers. It has been suggested that CDKAL1 might inﬂuence
the secretion of insulin by interacting with CDK5 (21). Our
data contributes another piece of evidence supporting the
hypothesis, namely, that the same genotype conferring
lower birth weight can also confer higher type 2 diabetes
risk later in life. CDKAL1 was ﬁrst described in the
context of type 2 diabetes in both European Caucasians
and in Han Chinese (21); as such, it would be interesting to
examine whether the association of CDKAL1 with lower
birth weight also stands in this and other ethnicities, such
as African Americans and Hispanics.
In conclusion, we strongly conﬁrm that the established
type 2 diabetes locus CDKAL1 also inﬂuences birth
weight. However, we do not observe such association with
TCF7L2, HHEX-IDE, CDKN2A/2B,o rJAZF1. In addition,
of all the other established type 2 diabetes loci to date, we
do not observe a convincing role for them in the determi-
nation of birth weight.
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